viernes, 1 de mayo de 2026

What does Akeso’s primo plenary spot say about its survival data? Mystery cloaks an ASCO plenary lung cancer survival result By Adam FeuersteinApril 30, 2026 Senior Writer, Biotech

https://www.statnews.com/2026/04/30/akeso-summit-therapeutics-drug-ivonescimab-results-announced-asco/

No hay comentarios:

Publicar un comentario